The French ecology of medical care. A nationwide population-based cross sectional study.

general practice health research system primary care

Journal

Family practice
ISSN: 1460-2229
Titre abrégé: Fam Pract
Pays: England
ID NLM: 8500875

Informations de publication

Date de publication:
02 Nov 2023
Historique:
medline: 7 11 2023
pubmed: 7 11 2023
entrez: 7 11 2023
Statut: aheadofprint

Résumé

Studies in the United States, Canada, Belgium, and Switzerland showed that the majority of health problems are managed within primary health care; however, the ecology of French medical care has not yet been described. Nationwide, population-based, cross sectional study. In 2018, we included data from 576,125 beneficiaries from the General Sample of Beneficiaries database. We analysed the reimbursement of consultations with (i) a general practitioner (GP), (ii) an outpatient doctor other than a GP, (iii) a doctor from a university or non-university hospital; and the reimbursement of (iv) hospitalization in a private establishment, (v) general hospital, and (vi) university hospital. For each criterion, we calculated the average monthly number of reimbursements reported on 1,000 beneficiaries. For categorical variables, we used the χ2 test, and to compare means we used the z test. All tests were 2-tailed with a P-value < 5% considered significant. Each month, on average, 454 (out of 1,000) beneficiaries received at least 1 reimbursement, 235 consulted a GP, 74 consulted other outpatient doctors in ambulatory care and 24 in a hospital, 13 were hospitalized in a public non-university hospital and 10 in the private sector, and 5 were admitted to a university hospital. Independently of age, people consulted GPs twice as much as other specialists. The 13-25-year-old group consulted the least. Women consulted more than men. Individuals covered by complementary universal health insurance had more care. Our study on reimbursement data confirmed that, like in other countries, in France the majority of health problems are managed within primary health care.

Identifiants

pubmed: 37934751
pii: 7338780
doi: 10.1093/fampra/cmad098
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Catherine Laporte (C)

Département de Médecine Générale, Université Clermont Auvergne, UFR de Médecine et Profession paramédicales de Clermont-Ferrand, F-63000 Clermont-Ferrand, France.
Clermont Auvergne INP, CHU Clermont-Ferrand, CNRS, Institut Pascal, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.

Frédéric Fortin (F)

Département de Médecine Générale, Université Clermont Auvergne, UFR de Médecine et Profession paramédicales de Clermont-Ferrand, F-63000 Clermont-Ferrand, France.
Clermont Auvergne INP, CHU Clermont-Ferrand, CNRS, Institut Pascal, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.

Julie Dupouy (J)

Maison de Santé Pluriprofessionnelle Universitaire de Pins Justaret, Pins Justaret, France.
Département universitaire de médecine générale, UFR Santé, Université Toulouse III Paul Sabatier, Toulouse, France.
UMR 1295 Inserm CERPOP, Université Toulouse III, F-31000 Toulouse, France.

David Darmon (D)

Département d'Enseignement et de Recherche de Médecine Générale, Université Côte d'Azur, RETINES, UFR médecine 28, Avenue de Valombrose, Nice, 06107, France.

Bruno Pereira (B)

CHU Clermont-Ferrand, University Hospital of Clermont-Ferrand, Biostatistics Unit, the Clinical Research and Innovation Direction, Clermont-Ferrand, France.

Nicolas Authier (N)

CHU Clermont-Ferrand, Service de Pharmacologie médicale, Centres Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Inserm 1107, Neuro-Dol, Université Clermont Auvergne, F-63000, Clermont-Ferrand, France.

Jessica Delorme (J)

CHU Clermont-Ferrand, Service de Pharmacologie médicale, Centres Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Inserm 1107, Neuro-Dol, Université Clermont Auvergne, F-63000, Clermont-Ferrand, France.

Chouki Chenaf (C)

CHU Clermont-Ferrand, Service de Pharmacologie médicale, Centres Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Inserm 1107, Neuro-Dol, Université Clermont Auvergne, F-63000, Clermont-Ferrand, France.

Hubert Maisonneuve (H)

Faculty of Medicine, University Institute for Primary Care, University of Geneva, Geneva, Switzerland.

Matthieu Schuers (M)

Département de Médecine Générale, Normandie Université, UFR Santé Rouen, F-7600 Rouen, France.
Department of Biomedical Informatics, CHU Rouen, F-76000 Rouen, France.
INSERM, U1142, Laboratoire d'Informatique Médicale et d'Ingénierie des Connaissances en e-Santé, LIMICS, Sorbonne Université, F-75006 Paris, France.

Classifications MeSH